National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, raised $625 million in a Series D financing, in addition to a previously unannounced $600 million Series C financing completed in August 2021.   The company will use the funding to continue to invest in building its infrastructure network through strategic collaborations, acquisitions, organic growth and international expansion, and by developing innovative...